Fig 1.
NMBA: neuromuscular-blocking agent; RASS: Richmond Assessment Sedation Scale.
Table 1.
Patient characteristics.
Table 2.
Neurological assessment at the time of inclusion.
Fig 2.
Representation of homogeneous and heterogeneous profiles.
The percentage of abolition of each tested neurological responses in homogeneous and heterogeneous profiles are depicted. The heterogeneous profile is characterized by a greater and more heterogeneous abolition of neurological responses.
Table 3.
Latent class description and outcomes.
Table 4.
Association between heterogeneous sub-phenotype and 28-day mortality.
Fig 3.
28-day mortality probability according to the BRASS.
Mortality probability expressed in mean [95%CI], BRASS: Brainstem Responses Assessment Sedation Score.